| Authors: |
Gibson LP; National Cancer Institute, National Institutes of Health, Rockville, United States., Parks MJ; National Institute on Drug Abuse, National Institutes of Health, Bethesda, United States; Kelly Government Solutions, Bethesda, United States., Kimmel HL; National Institute on Drug Abuse, National Institutes of Health, Bethesda, United States., Blanco C; National Institute on Drug Abuse, National Institutes of Health, Bethesda, United States., Ciccolo JT; National Cancer Institute, National Institutes of Health, Rockville, United States., Creamer MR; National Institute on Drug Abuse, National Institutes of Health, Bethesda, United States., Everard C; National Institute on Drug Abuse, National Institutes of Health, Bethesda, United States; Kelly Government Solutions, Bethesda, United States., Freedman ND; National Cancer Institute, National Institutes of Health, Rockville, United States., Garcia M; National Institute on Drug Abuse, National Institutes of Health, Bethesda, United States; Kelly Government Solutions, Bethesda, United States., Kingsbury JH; National Institute on Drug Abuse, National Institutes of Health, Bethesda, United States; Kelly Government Solutions, Bethesda, United States., Lee YO; National Cancer Institute, National Institutes of Health, Rockville, United States., Marshall D; National Institute on Drug Abuse, National Institutes of Health, Bethesda, United States; Axle Informatics, Rockville, United States., Compton WM; National Institute on Drug Abuse, National Institutes of Health, Bethesda, United States., Kaufman A; National Cancer Institute, National Institutes of Health, Rockville, United States. Electronic address: kaufmana@mail.nih.gov. |